**About**
941 results
30 - 129
Patient Education: Overview in Diabetes
COVID-19: Managing Stress And Coping- COVID-19: Are We Getting Ahead?
- COVID-19 Update: Therapies and Vaccines
- Nutrition for Type 1 Diabetes
Darbepoetin alfa- Antibiotic (Ab) Use in the Time of Covid-19
- COVID-19 Vaccine Updates: Current Recommendations
- New Opportunities for Mitigating Diabetes Risk
- Heart Failure
Phenelzine- Tranylcypromine
- A COVID-19 Conversation - Variants, Vaccines, and Long-Term Effects
- Measles: Important Updates for Clinicians and Patients
Coronavirus- Communication Disorders
- Alzheimer Disease
- ACE inhibitors
- Cholera vaccine
- Campylobacter jejuni
- Cholera vaccine
- Adherence
- Separation Anxiety Disorder
- Dysthymia
- Bulimia Nervosa
- Nonadherence
- Monkeypox Update: Common Questions Answered by Dr. Paul Auwaerter of Johns Hopkins
HIV- Dear Colleague: September 27 is National Gay Men's HIV/AIDS Awareness Day (NGMHAAD)
- Join Us in Sharing and Promoting Together TakeMeHome (TTMH)
- Dear Colleague: February 7 is National Black HIV/AIDS Awareness Day (NBHAAD)
- HIV Infographics Library
- Dear Colleague: National HIV Testing Day is June 27!
- HIV in the United States by Region
- HIV in the US by Race/Ethnicity
- HIV and Transgender People
- HIV in the US by Age
- HIV and Women Web Content and Fact Sheet
- Cluster Detection and Response FAQs
- HIV and African American People Web Content and Fact Sheet
- Monoamine Oxidase Inhibitors (MAOI)
- Ezetimibe
- Housing Problems
- Gestational Diabetes
- Amoxicillin
- Furuncle/Carbuncle
- COVID-19 Update with Dr. Paul Auwaerter of Johns Hopkins : Omicron Variant, Testing, and Treatment
- Terbinafine
- Amoxicillin + Clavulanate
- Insulinoma
- Metformin
- Genital/Anogenital Warts
- Rimantadine
- Guanfacine
- Preventing HIV in 2025: Primary Care and Psychiatry at the Forefront of Prep
- Quinupristin + Dalfopristin
- Menopausal Effects on Glycemia
- Health Alert Network (HAN)
- Outbreak of Ebola virus disease (Sudan ebolavirus) in Central Uganda - Health Alert Network (HAN) No. 477
- Rapid Increase of Omicron Variant Infections in the United States: Management of Healthcare Personnel with SARS-CoV-2 Infection or Exposure - Health Alert Network (HAN) No. 460
- New SARS-CoV-2 Variant of Concern Identified: Omicron (B.1.1.529) Variant - Health Alert Network (HAN) No. 459
- Outbreak of Pneumonia of Unknown Etiology (PUE) in Wuhan, China - Health Alert Network (HAN) No. 424
- Depression
- Narcolepsy
- Culture-bound Syndromes
- Rumination Disorder
- Lactobacillus
- Educational Problems
- Paraphilic Disorders
- Patient Education: Overcoming Barriers in Diabetes
- Ampicillin
- CDC Online Newsroom
- HHV 8
- Gender Dysphoria
- PDE-5 inhibitors
- Mycobacterium leprae
- Cycloserine
- Clostridioides (previously Clostridium) difficile
- Bipolar II Disorder
- Driving with Diabetes
- Gambling Disorder
- Mycobacterium avium-complex (MAC, MAI, non-HIV)
- Gnathostomiasis
- Colorado Tick Fever
- Bipolar I Disorder
- Anthrax vaccine
- Lenacapavir
- Body Dysmorphic Disorder
- Sex Hormones
- Rotavirus
- Anthrax vaccine
- Antisocial Personality Disorder
- Pancreas and Islet Transplantation
- Endocarditis
- PCSK9 Inhibitors
- Disaster Emergency Preparedness in Diabetes
- Empyema and Parapneumonic Effusions